Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | KR | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | FR | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | ES | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | JP | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | GB | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | NL | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | IT | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | DE | 25 May 2023 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | US | 25 May 2023 |